Page 5 - Medication Access News Today

Prompted by rising rates of overdose deaths, suicides and incidence of mental illness in at-risk populations, such as children, Congress has spent the better part of the year working in...

On TikTok, users are warning that the overturn of Roe v. Wade could lead to the criminalization of other medicines.

Church Briefs Penn Yan First Baptist First Baptist Church would like to give a shout-out to Diane Trickey-Morse and her BSA Troop #444, for the awesome job they did on the grounds of the church as the girls have been weeding to earn their Community Service badge. They also plan to go white water rafting and attend camp. We so appreciate the loyalty to their uniform and for the work on our church grounds.  The Penn Yan Community Summer Happenings held June 28 through July 2 was a huge success. ...

NAMAPA Announces New Dates for 2021 Healthcare Advocate Summit Share Article Healthcare Advocate Summit Past News ReleasesRSS GALVESTON, Texas (PRWEB) April 15, 2021 The 2021 Healthcare Advocate Summit, presented by the National Association of Medication Access & Patient Advocacy (NAMAPA), announced today its inaugural summit is taking place on September 8-10, 2021. The three-day summit will be held at the Galveston Island Convent...

email article As COVID-19 engulfed the country, drug overdose deaths surged, and untreated substance use disorder (SUD) continued to cut short the lives of thousands of Americans. Data from the CDC show that drug overdose deaths in the U.S. are at their highest level on record, soaring to more than 87,000 deaths in the 12-month period ending in September 2020. While it is easy to become desensitized to numbers on a page, the pain is all too real for the families like ours who have lost lo...

On January 14, 2021, days before a change in presidential administrations, the US Department of Health and Human Services (HHS) announced a plan to publish Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder “pursuant to 21 USC §823(g)(2)(H)(i)(II),” a provision of the Drug Addiction and Treatment Act of 2000 (DATA 2000). 1 This announcement caused a mix of enthusiasm, skepticism, and confusion in the medical community, and the retraction of the pla...